PubRank

Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry

Clinical Trial ID NCT02778646

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02778646

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009 19.23
2 Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 2006 7.83
3 Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013 3.58
4 Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis 1999 3.33
5 Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature 2014 3.29
6 Triggering of myocardial infarction by cocaine. Circulation 1999 3.06
7 A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003 2.97
8 Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008 2.62
9 Type 1 diabetes and coronary artery disease. Diabetes Care 2006 2.47
10 Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2007 1.91
11 Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012 1.70
12 Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004 1.61
13 Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation 2011 1.51
14 Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation 2014 1.32
15 Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011 1.22
16 The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis 2005 1.20
17 Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol 2008 1.14
18 Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 2001 1.09
19 Multiple imputation for completion of a national clinical audit dataset. Stat Med 2011 0.96
20 Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol 2013 0.94
21 Effect of acute myocardial infarction on cholesterol ratios. Chest 2001 0.91
22 Clinical utility of lipid and lipoprotein levels during hospitalization for acute myocardial infarction. Vasc Med 1999 0.91
23 Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers. Atherosclerosis 2014 0.90
24 Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT). Atherosclerosis 2014 0.85
25 Prevalence and treatment of familial hypercholesterolaemia in Australian communities. Int J Cardiol 2015 0.85
26 Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population. Oman Med J 2014 0.84
27 Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methods. Heart Lung Circ 2014 0.81
28 Cocaine use and the likelihood of cardiovascular and all-cause mortality: data from the Third National Health and Nutrition Examination Survey Mortality Follow-up Study. J Vasc Interv Neurol 2014 0.80
29 Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review. Clin Chem 2010 0.80
30 Cutoff point separating affected and unaffected familial hypercholesterolemic patients validated by LDL-receptor gene mutants. J Atheroscler Thromb 2005 0.80
31 Detecting familial hypercholesterolaemia in general practice. Aust Fam Physician 2012 0.79
32 Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010. J Am Heart Assoc 2014 0.79
33 Polygenic familial hypercholesterolaemia: does it matter? Lancet 2013 0.78
34 Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States. Int J Cardiol 2014 0.78
35 Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales. Atherosclerosis 2015 0.78
36 Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement. Genet Med 2015 0.77
37 Cardiac complications of cocaine abuse. Clin Cardiol 1995 0.77
38 Changes in low-density lipoprotein cholesterol levels after discharge for acute myocardial infarction in a real-world patient population. Am J Epidemiol 2014 0.77
39 Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia? Atherosclerosis 2015 0.77
40 Can patients be accurately assessed for familial hypercholesterolaemia in primary care? Heart Lung Circ 2014 0.75
41 Cocaine-associated myocardial infarction: should they all be stented? Case Rep Cardiol 2011 0.75
42 A contemporary risk model for predicting 30-day mortality following percutaneous coronary intervention in England and Wales. Int J Cardiol 2016 0.75
43 Erratum: Identification of the gene defect responsible for severe hypercholesterolaemia using whole-exome sequencing. Sci Rep 2015 0.75
44 Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction. Eur J Intern Med 2015 0.75
Next 100